Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.15%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information
Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSYNDAX PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SNDX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 898K | 1.15% | $ 78.18M |
| 3/31/2025 | $ 971K | 2.22% | $ 43.72M |
| 12/31/2024 | $ 997K | 4.21% | $ 23.68M |
| 9/30/2024 | $ 1.03M | 6.47% | $ 16M |
| 6/30/2024 | $ 978K | 27.94% | $ 3.5M |
| 3/31/2024 | $ 885K | 0% | $ 0 |
| 12/31/2023 | $ 751K | 0% | $ 0 |
| 9/30/2023 | $ 620K | 0% | $ 0 |
| 6/30/2023 | $ 488K | 0% | $ 0 |
| 3/31/2023 | $ 446K | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 78.76%.
- Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average DepAmor % has been 16%.
- The median DepAmor % for SYNDAX PHARMACEUTICALS INC during this period was 3.81%
- SYNDAX PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 78.76%.
- The lowest DepAmor % recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe 0.33%
SYNDAX PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for SYNDAX PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 1.19M ] / Revenues [ $ 1.52M ]
(=) DepAmor % [ 78.76% ] SNDX - Depreciation and Amortization Margin, Last 5 years
0.33%
Minimum
Dec 31, 2021
78.76%
Maximum
Sep 30, 2020
16%
Average
3.81%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |